Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
An open-label, multi-centre, 26-weeks clinical feasibility study. The objective is to explore
whether Saxenda could be a feasible choice in the treatment of overweight, obesity and
weight-related medical problems, in patients diagnosed with a severe mental illness and
hospitalized at a forensic department in Denmark. We wish to determine the viability of the
daily Saxenda®-injection treatment in this specific patient group.